Level C· Early human research exploring benefitsCase Report / SeriesPubMed

High-Density Fat Combined With Stromal Vascular Fraction Gel for the Treatment of Facial Localized Scleroderma.

Zheng Y., Hu Y., Wang H., Miao C.

Case Report / Series on Face & Skin, published in J Craniofac Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
J Craniofac Surg (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
39750718
DOI
10.1097/SCS.0000000000010953

Abstract (original English)

Patients with localized scleroderma on the face typically exhibit asymmetrical linear or patchy skin lesions and indentations on areas such as the scalp and forehead, with a smooth, waxy surface. In the early stages, medication is used to control the progression of the disease. In later stages, plastic surgery is performed to repair facial skin lesions. The authors treated 2 patients with localized scleroderma of the face using high-density fat combined with stromal vascular fraction gel transplantation surgery. The patients were satisfied with the color and texture of their skin, as it closely resembled the surrounding normal skin. In addition, the facial indentations were corrected, restoring a normal appearance to the face. This method is aesthetically pleasing, durable, and safe.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansAdipose TissueFacial DermatosesGelsScleroderma, LocalizedStromal Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research